NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)
SNSS Technical Analysis
2
As on 31st Oct 2017 SNSS Share Price closed @ 2.56 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.18 & Strong Buy for SHORT-TERM with Stoploss of 2.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNSS Share Price
Open | 2.23 | Change | Price | % |
High | 2.65 | 1 Day | 0.41 | 19.07 |
Low | 2.16 | 1 Week | 0.00 | 0.00 |
Close | 2.56 | 1 Month | 0.34 | 15.32 |
Volume | 661722 | 1 Year | -1.51 | -37.10 |
52 Week High 4.45 | 52 Week Low 1.82 |
NASDAQ USA Most Active Stocks
YHOO | 52.58 | 0.00% |
FNFG | 10.18 | -0.20% |
DELL | 13.86 | 0.22% |
RFMD | 16.59 | -2.07% |
MU | 44.31 | 6.39% |
RIMM | 13.03 | 0.39% |
BBEP | 0.12 | 0.00% |
GTAT | 0.44 | 0.00% |
SUSQ | 14.20 | -0.77% |
INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
SNSS Daily Charts |
SNSS Intraday Charts |
Whats New @ Bazaartrend |
SNSS Free Analysis |
|
SNSS Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 3.01 |
RESISTANCE | 2.83 |
SUPPORT | 2.29 |
SUPPORT | 2.11 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SNSS Target for Month March
4th UP TARGET | 4.16 |
3rd UP TARGET | 3.65 |
2nd UP TARGET | 3.33 |
1st UP TARGET | 3.01 |
1st DOWN TARGET | 2.11 |
2nd DOWN TARGET | 1.79 |
3rd DOWN TARGET | 1.47 |
4th DOWN TARGET | 0.96 |
SNSS Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
SNSS Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Sunesis Pharmaceuticals, Inc. ( NASDAQ USA Symbol : SNSS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNSS Other Details
Segment | EQ | |
Market Capital | 190775152.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
SNSS Address
![]() |
395 Oyster Point Boulevard Suite 400 South San Francisco, CA 94080 United States Phone: 650-266-3500 Fax: 650-266-3501 |
SNSS Latest News
SNSS Business Profile
Sunesis Pharmaceuticals, Inc. (Sunesis) is a biopharmaceutical company focused on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The Company is focuses primarily on the development of vosaroxin for the treatment of acute myeloid leukemia (AML). Vosaroxin is a anti-cancer quinolone derivative (AQD). AQDs have been shown to mediate anti-tumor activity by targeting mammalian topoisomerase II, an enzyme critical for cell replication. The Company owns worldwide development and commercialization rights to vosaroxin. The Company�s VALOR trial is designed to evaluate the effect of vosaroxin in combination with cytarabine, chemotherapy in AML. The trial has an adaptive design and is based on data from the Company's Phase II clinical trial of vosaroxin in combination with cytarabine in relapsed or refractory AML.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service